Answers are grounded in this paper and cite their sources.
Case report demonstrates complete radiologic response following sequential locoregional therapy in advanced hepatocellular carcinoma, suggesting viability for liver-confined vascular invasion.
Hepatocellular carcinoma (HCC) with macrovascular invasion is classified as Barcelona Clinic Liver Cancer stage C, for which systemic therapy is generally recommended.We report a 68-year-old male with chronic hepatitis B. Magnetic resonance imaging revealed a 9.1-cm HCC with tumor thrombi involving branches of the right hepatic vein and posterior segmental portal vein; staging showed no extrahepatic metastasis.Serum alpha-fetoprotein was within the reference range, whereas protein induced by vitamin K absence or antagonist-II (PIVKA-II) was elevated.After multidisciplinary review, transarterial radioembolization (TARE) was selected for this liver-confined tumor.TARE was performed, followed by consolidative conventional transarterial chemoembolization (cTACE) for persistent viable tumor and external beam radiotherapy (EBRT) to the vascular tumor thrombi.Follow-up computed tomography showed no residual arterial enhancement in the treated intrahepatic lesion, meeting modified Response Evaluation Criteria in Solid Tumors for complete response of the treated target lesion.PIVKA-II normalized after treatment, and hepatic function remained Child-Pugh class A and albuminbilirubin grade 1 throughout, and no treatment-related complication occurred.This case illustrates the feasibility of a TARE-based sequential strategy, with consolidative cTACE and EBRT, for local control in a highly selected patient with liver-confined HCC and segmental portal and hepatic vein tumor thrombosis.
No takes yet. Share an insight, caveat, or question.
Jeong et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: